DOT1L and colorectal carcinoma: Other studies have reported that interleukin 22 (IL-22), produced by CD4 (+) T cells in CRC tissues, promote activation of transcription factor STAT3 and the expression of DOT1 Like Histone Lysine Methyltransferase (DOT1L).